Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Operating Expenses | 10,520 | 7,850 | 9,180 | 7,900 | 6,080 |
| Operating Income | -10,520 | -7,850 | -9,180 | -7,900 | -6,080 |
| Interest Expense | 400 | 420 | 440 | 460 | 347 |
| Other Income | 1,330 | 1,320 | 1,100 | 640 | 287 |
| Pre-tax Income | -9,590 | -6,950 | -8,520 | -7,720 | -6,140 |
| Net Income Continuous | -9,566 | -6,959 | -8,528 | -7,729 | -6,121 |
| Net Income | $-9,566 | $-6,959 | $-8,528 | $-7,729 | $-6,121 |
| EPS Basic Total Ops | -11.20 | -8.00 | -11.20 | -13.60 | -10.80 |
| EPS Basic Continuous Ops | -11.04 | -8.03 | -11.09 | -13.55 | -10.73 |
| EPS Diluted Total Ops | -11.20 | -8.00 | -11.20 | -13.60 | -10.80 |
| EPS Diluted Continuous Ops | -11.04 | -8.03 | -11.09 | -13.55 | -10.73 |
| EBITDA(a) | $-9,940 | $-7,260 | $-8,610 | $-7,340 | $-5,580 |